Burr is mentioned as part of the committee proceedings.
01/16/2018
https://www.congress.gov...
Without Orrin, we wouldn't have a generic drug industry.
How could you not have passed this into law by now? I mean, this sounds like a panacea.
I oppose Ms. Kotagal's nomination and urge my colleagues to do the same.
I am concerned Ms. Kotagal lacks impartiality to interpret the law.